What is the ideal treatment for individuals who carry one of the thrombophilic traits?
The ideal treatment for individuals who carry one of the thrombophilic traits is uncertain, however, adhering to deep vein thrombosis treatment recommendations seems reasonable if they otherwise meet eligibility criteria. If testing for these hematologic traits is considered in certain clinical scenarios, testing for protein C, protein S, or antithrombin levels should be deferred or repeated at least 4 to 6 weeks (or up to 6 months for factor VIII609 ) after the acute stroke given that these protein levels may be altered during the acute stroke phase.